FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+22.3%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$455M
AUM Growth
+$455M
(+25%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
56.91%
Holding
55
New
3
Increased
34
Reduced
5
Closed
3
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$23.5M |
| 2 |
SHPG
Shire pic
SHPG
|
$15M |
| 3 |
NeoGenomics
NEO
|
$7.45M |
| 4 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
$5.39M |
| 5 |
Harvard Bioscience
HBIO
|
$4.01M |
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$16.4M |
| 2 |
Nektar Therapeutics
NKTR
|
$5.49M |
| 3 |
QuidelOrtho
QDEL
|
$2.27M |
| 4 |
BLUE
bluebird bio
BLUE
|
$2.12M |
| 5 |
Codexis
CDXS
|
$1.88M |
Sector Composition
| 1 | Healthcare | 84.88% |
| 2 | Communication Services | 4.24% |
| 3 | Energy | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $38.8M | 8.53% | 4,760,332 +912,730 | +24% | +$7.45M |
|
|
2
Nektar Therapeutics
NKTR
$568M
| $31.9M | 7% | 300,086 -51,655 | -15% | -$5.49M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $27.3M | 6% | 1,675,148 +108,344 | +7% | +$1.77M |
|
|
4
Harvard Bioscience
HBIO
$22M
| $27.2M | 5.97% | 5,441,290 +802,639 | +17% | +$4.01M |
|
|
SHPG
5
DELISTED
Shire pic
SHPG
| $26.9M | 5.9% | 179,976 +100,369 | +126% | +$15M |
|
6
AtriCure
ATRC
$1.84B
| $24M | 5.26% | 1,167,672 +92,225 | +9% | +$1.89M |
|
|
7
Tandem Diabetes Care
TNDM
$845M
| $23.5M | 5.16% | +4,734,238 | New | +$23.5M |
|
8
Xencor
XNCR
$580M
| $20.9M | 4.59% | 697,756 +52,992 | +8% | +$1.59M |
|
|
MODN
9
DELISTED
MODEL N, INC.
MODN
| $19.3M | 4.24% | 1,070,023 +125,898 | +13% | +$2.27M |
|
10
Ligand Pharmaceuticals
LGND
$3.15B
| $19.3M | 4.24% | 116,808 +4,837 | +4% | +$799K |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $14.9M | 3.27% | 1,019,920 +75,516 | +8% | +$1.1M |
|
12
Omnicell
OMCL
$1.5B
| $14.7M | 3.22% | 338,113 +20,782 | +7% | +$902K |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $14.5M | 3.17% | 166,744 +10,840 | +7% | +$940K |
|
14
Heron Therapeutics
HRTX
$207M
| $13.1M | 2.87% | 473,275 +59,554 | +14% | +$1.64M |
|
|
CSII
15
DELISTED
Cardiovascular Systems, Inc.
CSII
| $10.3M | 2.26% | 469,687 +25,683 | +6% | +$563K |
|
16
Halozyme
HALO
$8.56B
| $9.85M | 2.16% | 503,029 +35,383 | +8% | +$693K |
|
17
Dynavax Technologies
DVAX
$1.19B
| $9.01M | 1.98% | 453,634 +38,061 | +9% | +$756K |
|
18
Globus Medical
GMED
$8.27B
| $8.93M | 1.96% | 179,264 +2,807 | +2% | +$140K |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.8M | 1.71% | 626,585 +29,807 | +5% | +$371K |
|
|
XENT
20
DELISTED
Intersect ENT, Inc
XENT
| $7.44M | 1.63% | 189,231 +10,335 | +6% | +$406K |
|
|
21
Codexis
CDXS
$246M
| $6.97M | 1.53% | 633,665 -170,559 | -21% | -$1.88M |
|
22
Bio-Techne
TECH
$8.5B
| $5.84M | 1.28% | 38,655 +584 | +2% | +$88.2K |
|
23
HealthStream
HSTM
$832M
| $5.5M | 1.21% | 221,668 +12,081 | +6% | +$300K |
|
|
NVTR
24
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $5.39M | 1.18% | +413,646 | New | +$5.39M |
|
|
KTWO
25
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.21M | 1.14% | 275,068 +4,310 | +2% | +$81.7K |
|